Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 18, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	362	307	65	7	9	33
Market Cap Growth	35.73%	369.05%	881.17%	-29.60%	-71.60%	294.06%
Enterprise Value	174	205	52	1	2	22
Last Close Price	10.57	11.70	6.99	4.05	19.72	72.25
PS Ratio	-	-	-	88.98	129.85	565.78
PB Ratio	1.93	3.16	1.39	33.04	3.29	1.67
P/TBV Ratio	1.93	3.16	1.39	33.04	3.29	1.67
EV/Sales Ratio	-	-	-	9.94	23.51	367.04
Debt / Equity Ratio	0.01	0.01	0.01	2.77	0.28	0.01
Net Debt / Equity Ratio	-1.00	-1.00	-1.07	-9.49	-1.13	-0.98
Net Debt / EBITDA Ratio	3.89	2.32	2.26	0.10	0.18	1.46
Net Debt / FCF Ratio	10.18	4.11	2.58	0.11	0.20	1.50
Asset Turnover	-	-	-	0.01	0.01	0.00
Quick Ratio	67.45	54.26	10.38	0.64	1.61	14.46
Current Ratio	67.69	54.67	10.49	0.94	1.90	15.05
Return on Equity (ROE)	-33.50%	-52.46%	-91.68%	-1268.61%	-159.08%	-91.79%
Return on Assets (ROA)	-22.41%	-34.39%	-49.60%	-228.53%	-81.59%	-51.55%
Return on Capital Employed (ROCE)	-25.70%	-42.70%	-47.60%	-3926.10%	-518.90%	-67.90%
Earnings Yield	-12.18%	-12.35%	-33.22%	-293.13%	-192.09%	-41.59%
FCF Yield	-5.09%	-7.69%	-29.91%	-269.92%	-167.86%	-39.10%
Buyback Yield / Dilution	-24.88%	-97.17%	-1225.17%	-188.30%	-90.24%	-320.63%

Updated Feb 12, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q